Page last updated: 2024-12-07

chapso

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

chapso: RN given refers to (3alpha,5beta,7alpha,12alpha)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122145
SCHEMBL ID594591
MeSH IDM0139591

Synonyms (27)

Synonym
chapso, >=98%
chapso, bioxtra
chapso
82473-24-3
3-[dimethyl-[3-[[(4r)-4-[(3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]azaniumyl]-2-hydroxypropane-1-sulfonate
(2-hydroxy-3-sulfopropyl)-dimethyl-[3-[[(4r)-4-[(3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]azanium
3-((3-cholamidopropyl)dimethylammonio)-2-hydroxy-1-propane sulfonate
unii-v9n9rga14m
1-propanaminium, 2-hydroxy-n,n-dimethyl-3-sulfo-n-(3-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)propyl)-, hydroxide, inner salt
v9n9rga14m ,
SCHEMBL594591
3-([3-cholamidopropyl]dimethylammonio)-2-hydroxy-1-propanesulfonate
AKOS025286002
3-((3-cholamidopropyl)dimethylammonio)-2-hydroxy-1-propanesulfonate
1-propanaminium, 2-hydroxy-n,n-dimethyl-3-sulfo-n-(3-(((3.alpha.,5.beta.,7.alpha.,12.alpha.)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)propyl)-, inner salt
mfcd00081079
3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulphonate
CS-W020941
chapso, vetec(tm) reagent grade, >=98%
GUQQBLRVXOUDTN-XOHPMCGNSA-N
AS-35189
3-(dimethyl(3-((r)-4-((3r,5s,7r,8r,9s,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanamido)propyl)ammonio)-2-hydroxypropane-1-sulfonate
Q27291705
DTXSID901002705
3-(dimethyl{3-[(3,7,12,24-tetrahydroxycholan-24-ylidene)amino]propyl}azaniumyl)-2-hydroxypropane-1-sulfonate
3-[dimethyl-[3-[[(4r)-4-[(3r,5s,7r,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]azaniumyl]-2-hydroxypropane-1-sulfonate
A864403
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (64)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (18.75)18.7374
1990's23 (35.94)18.2507
2000's18 (28.13)29.6817
2010's11 (17.19)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.68 (24.57)
Research Supply Index4.19 (2.92)
Research Growth Index4.57 (4.65)
Search Engine Demand Index54.53 (26.88)
Search Engine Supply Index2.92 (0.95)

This Compound (30.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.54%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other64 (98.46%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]